SYNCOMF NSE filing

Syncom Formulations Announces 38th AGM on Sep 30, 2026, Shares FY26 Annual Report Link

The RealCase readLow impact Neutral

Syncom Formulations will hold its 38th AGM on September 30, 2026, via video conference. The Annual Report for FY 2025-26 is available online for shareholders. Letters are being sent to those with un-registered email addresses providing access details.

Why it matters

This is a standard procedural announcement related to regulatory compliance for the AGM and annual report dissemination. It does not involve any new financial outcomes, strategic shifts, or corporate actions that would significantly impact the company's operations or stock.

The market read

The announcement is a routine regulatory filing regarding the dispatch of the annual report and the schedule of the AGM. It does not contain any new financial performance data or significant strategic developments that would warrant a positive or negative sentiment.

Syncom Formulations (India) Limited has announced the dispatch of letters to shareholders who have not registered their email addresses. These letters contain a web link to access the complete details of the Annual Report for the Financial Year 2025-26, in compliance with Regulation 36(1)(b) of the SEBI (LODR) Regulations, 2015.

The 38th Annual General Meeting (AGM) of the company is scheduled to be held on Wednesday, September 30, 2026, at 2:00 P.M. The meeting will be conducted through Video Conferencing (VC)/Other Audio Visual Means (OAVM).

The Annual Report for the Financial Year ended March 31, 2026, along with the Notice of the 38th AGM, is available on the company's website (www.syncomformulations.com) and a specific web-link (https://syncomformulations.com/sil/si-financial-reports/). Shareholders can request a physical copy by writing to finance@sil.in. The documents are also available on the websites of BSE, NSE, and CDSL.

Filing to action

What to do with a filing like this

Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.

View original filing